CME Group's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 38.21.
CME Group's Days Inventory for the
three
months ended in Mar. 2026 was 0.
CME Group's Days Payable for the
three
months ended in Mar. 2026 was 30.12.
Therefore, CME Group's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 8.09.
CME Group (NAS:CME) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
CME Group Cash Conversion Cycle Related Terms
CME Group Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for CME Group's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME vs ICE, MCO, SPGI: Cash Conversion Cycle Comparison
For the Financial Data & Stock Exchanges subindustry, CME Group's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group Cash Conversion Cycle vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where CME Group's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
CME Group's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CME Group (CME) has a Cash Conversion Cycle of 8.09 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on CME Group and its competitors.
Is CME Group's Cash Conversion Cycle too high?
CME Group's current Cash Conversion Cycle is 8.09. The Capital Markets industry median Cash Conversion Cycle is 1.74. CME Group's value of 8.09 is 364.9% above this industry median. Overall, CME Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CME Group's Cash Conversion Cycle compare to ICE and MCO?
CME Group's Cash Conversion Cycle of 8.09 can be compared against companies in the Capital Markets industry. The industry median Cash Conversion Cycle is 1.74. CME Group's value of 8.09 is 364.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Capital Markets company?
The median Cash Conversion Cycle among Capital Markets companies is 1.74, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CME Group's current Cash Conversion Cycle of 8.09 is 364.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on CME Group and its competitors. For the Capital Markets industry, the median Cash Conversion Cycle is 1.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CME Group's current Cash Conversion Cycle is 8.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CME Group stock overvalued right now?
Based on GuruFocus' analysis, CME Group (CME) is currently considered Modestly Undervalued. The stock's GF Value™ is $270.96, compared to a current price of $221.00 — trading 18.4% below its estimated fair value. The current Cash Conversion Cycle is 8.09 and 364.9% above the Capital Markets industry median of 1.74. CME Group's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For CME Group (CME), the current Cash Conversion Cycle is 8.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CME Group (CME) Overvalued in 2026?
Based on GuruFocus' analysis, CME Group stock appears to be undervalued.
The current stock price of $221.00 is trading 18.4% below its estimated GF Value™ of $270.96.
GuruFocus considers CME Group to be Modestly Undervalued.
Key valuation signals for CME:
Cash Conversion Cycle: 8.09
GF Value™: $270.96 vs. price of $221.00 (18.4% below fair value)
Industry Position: 364.9% above the Capital Markets median
No single metric tells the full story. See the CME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indexes, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
93GF Score
Get the complete analysis for CME
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CME has been successfully added to your 
